Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24026858 | 0.96 | ALDH1A1 (0.35) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD | |
| SCHEMBL24026877 | 0.96 | ALDH1A1 (0.35) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD | |
| SCHEMBL24026732 | 0.92 | ALDH1A1 (0.36) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD | |
| SCHEMBL24026881 | 0.91 | ALDH1A1 (0.35) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD | |
| SCHEMBL24026870 | 0.91 | ALDH1A1 (0.35) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD | |
| SCHEMBL24026864 | 0.91 | ALDH1A1 (0.35) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD | |
| SCHEMBL24026879 | 0.89 | ALDH1A1 (0.35) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD | |
| SCHEMBL24026868 | 0.89 | ALDH1A1 (0.35) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD | |
| SCHEMBL24026865 | 0.89 | ALDH1A1 (0.35) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD | |
| SCHEMBL24026861 | 0.88 | ALDH1A1 (0.35) | ALDH1A1HSD17B10HIF1ACYP1B1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210359221-A1 | COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS USING THE SAME | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210359221-A1 | COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS USING THE SAME | HAX1, AFF4, XPO4 | ALDH1A1 1065/4885HSD17B10 2905/4885HIF1A 2743/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.